ScandiDos Stock

ScandiDos Equity

The The Equity of ScandiDos (SDOS.ST) as of Jul 31, 2026 is 41.66 M SEK. In the previous year, The Equity was 44.98 M SEK — a change of -7.38% (lower).

Equity

41.66 MSEK

YoY

-7.38%

Last updated:

In 2026, ScandiDos's equity was 41.66 M SEK, a -7.38% increase from the 44.98 M SEK equity in the previous year.

Access this data via the Eulerpool API

ScandiDos Stock analysis

What does ScandiDos do? ScandiDos AB is a leading company in the field of medical technology based in Uppsala, Sweden. The company was founded in 2002 and specializes in the development of innovative solutions for radiation therapy. ScandiDos AB is a subsidiary of ScandiDos Inc., a US-based company located in Madison, Wisconsin. The business model of ScandiDos AB is based on the development of high-quality, innovative products for radiation therapy and the provision of excellent services for customers. The company focuses on the needs of doctors, medical professionals, and patients, with the goal of constantly optimizing and improving the quality of radiation therapy. ScandiDos AB is divided into different divisions that focus on the specific requirements and needs of customers. One of these divisions is the development of advanced dosimeters for radiation therapy. ScandiDos AB's dosimeters are world-leading and can provide fast and precise real-time measurement of the radiation dose. They are designed for use in the radiation therapy of cancer patients and can ensure that patients receive an effective dosage that fights tumor growth while sparing the surrounding tissue. Another important division of ScandiDos AB is the provision of training and support for customers. The company offers a wide range of training, courses, and support for doctors, business partners, and medical professionals to ensure that customers have the necessary knowledge and skills to effectively use and utilize ScandiDos AB's dosimeters and other products. The training is conducted by experienced specialists and tailored to the specific needs of customers. ScandiDos AB's product range also includes specialized software tools for radiation therapy. This includes, for example, the Delta4® Phantom simulator, which allows for a simulation of radiation therapy to achieve the best results. In addition, ScandiDos AB offers other software tools for measuring and monitoring the radiation dose. ScandiDos AB has an extensive network of international partners and business associates who support the company in providing its products and services. The partners are represented in various countries worldwide and ensure that ScandiDos AB's products and services are available everywhere in the world. Overall, ScandiDos AB has become a company that focuses on quality, innovation, and customer satisfaction. The company's products and services contribute to improving the results of radiation therapy and increasing the quality of life for cancer patients worldwide. ScandiDos is one of the most popular companies on Eulerpool.

Equity Details

Analyzing ScandiDos's Equity

ScandiDos's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ScandiDos's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ScandiDos's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ScandiDos's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ScandiDos’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ScandiDos stock

The Equity of ScandiDos is 41.66 M SEK in 2026.

Access this data via the Eulerpool API

Balance Sheet — ScandiDos

All Key Metrics — ScandiDos